We are live on ! Find out more
EVH icon

Evolent Health

69 hedge funds and large institutions have $252M invested in Evolent Health in 2015 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 15

47% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 15

13% more funds holding

Funds holding: 6169 (+8)

0.98% more ownership

Funds ownership: 37.09%38.06% (+0.98%)

13% less capital invested

Capital invested by funds: $288M → $252M (-$36.4M)

Holders
69
Holders Change
+8
Holders Change %
+13.11%
% of All Funds
1.93%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
23
Increased
22
Reduced
15
Closed
15
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Alyeska Investment Group
76
Alyeska Investment Group
Illinois
-$1.36M -70,000 Closed
Jennison Associates
77
Jennison Associates
New York
-$972K -49,826 Closed
LCM
78
Landscape Capital Management
New Jersey
-$729K -37,400 Closed
OAC
79
OMERS Administration Corp
Ontario, Canada
-$521K -26,700 Closed
ACH
80
ArrowMark Colorado Holdings
Colorado
-$390K -20,000 Closed
BlackRock
81
BlackRock
New York
-$123K -6,300 Closed
MWP
82
MYCIO Wealth Partners
Pennsylvania
-$39K -2,000 Closed
MCM
83
Mazama Capital Management
Oregon
-$35K -1,777 Closed
FANJ
84
Financial Architects (New Jersey)
New Jersey
-$20K -1,000 Closed

EVH Hedge Fund Activity: Q3 2015 in Review

69 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q3 2015, worth a combined $252M — down 13% from $288M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new EVH positions and 15 closed out — a net gain of 8 holders — while 22 added to existing stakes and 15 trimmed.

The largest buyer was Vanguard Group, adding an estimated $12.3M. The largest seller was Carlson Capital, exiting entirely with an estimated $8.79M sold.

  • 69 institutional investors held Evolent Health (EVH) as of Q3 2015, up from 61 in Q2 2015.
  • Funds reported $252M of Evolent Health stock for Q3 2015, down 13% quarter-over-quarter.
  • 23 funds opened new Evolent Health positions in Q3 2015 and 15 closed out, a net change of +8 holders.
  • The largest Evolent Health buyer in Q3 2015 was Vanguard Group, an estimated $12.3M added.
  • The largest Evolent Health seller in Q3 2015 was Carlson Capital, an estimated $8.79M sold.

Based on aggregated 13F filings for Q3 2015.